Skip to main content

Together we are beating cancer

Donate now

Cancer News

Research and trials

Showing 12 out of 1697 results
A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

2D image of scientist hands with a cancer vaccine vial and needle
  • Science & Technology
  • Health & Medicine

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 20 November 2025

20 November 2025

A microscope image of cervical cells that have changed shape and size because of HPV infection. Most of the cells are blue, but some are pink or purple.
  • Science & Technology
  • Health & Medicine

From pre-cancer to cancer prevention

Studying pre-cancers helps us understand how and why cancer develops – and it can lead to new ways of stopping the process in its tracks Studying pre-cancers helps us understand how and why cancer develops – and it can lead to new ways of stopping the process in its tracks

by Tim Gunn | In depth | 19 November 2025

19 November 2025

A microscopic image of two lung cancer cells dividing, held together by a very thin bridge of cytoplasm.

With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine. With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine.

by Amal Iman | News | 17 November 2025

17 November 2025

A pill in a petri dish. The Pill is transparent but contains a compressed black sponge. There is a light blue thread attached to one end.
  • Health & Medicine
  • Science & Technology

Meet the capsule sponge

This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks. This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks.

by Amal Iman | In depth | 13 November 2025

13 November 2025

A cluster of different sized pink cells seen through a microscope.

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

by Henry Scowcroft | In depth | 13 November 2025

13 November 2025

Squamous epithelial cells of human cervix under the microscope view.
  • Science & Technology
  • Health & Medicine

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 13 November 2025

13 November 2025

A computer generated image showing two DNA helices in shades of blue.

A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients. A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients.

by Amal Iman | News | 7 August 2025

7 August 2025

A computer graphic showing three researchers working in a lab. Above them are three white bubbles howing the bacteria in the gut microbiome, a 'drug made from a bug' and cancer cells being targeted by immune cells.

By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'. By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'.

by Helen Renshaw | Analysis | 22 July 2025

22 July 2025

A magnified image of squamous cell carcinoma, the most common type of cervical cancer.

We've awarded £457,000 to support a study in Cambridge that could be a more comfortable method of collecting potentially harmful cells from the cervix. We've awarded £457,000 to support a study in Cambridge that could be a more comfortable method of collecting potentially harmful cells from the cervix.

by Sophie Wedekind, Patrick Keely | News | 21 July 2025

21 July 2025